847675-82-5

Basic information

• Product Name: 2-bis(tert-butoxycarbonyl)amino-4,6-dichloropyrimidine
• Synonyms: 2-bis(tert-butoxycarbonyl)amino-4,6-dichloropyrimidine
• CAS NO: 847675-82-5
• Molecular Formula: C14H19Cl2N3O4
• Molecular Weight: 364
• Mol File: 847675-82-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-bis(tert-butoxycarbonyl)amino-4,6-dichloropyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bis(tert-butoxycarbonyl)amino-4,6-dichloropyrimidine(847675-82-5)
• EPA Substance Registry System: 2-bis(tert-butoxycarbonyl)amino-4,6-dichloropyrimidine(847675-82-5)

Safety Data

• Hazardous Substances Data: 847675-82-5(Hazardous Substances Data)

Upstream product

• 56-05-3 2-Amino-4,6-dichloropyrimidine 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

Hierarchical self-assembly of a bow-shaped molecule bearing self-complementary hydrogen bonding sites into extended supramolecular assemblies

The bow-shaped molecule 1 bearing a self-complementary DAAD-ADDA (D = donor A = acceptor) hydrogen-bonding array generates, in hydrocarbon solvents, highly ordered supramolecular sheet aggregates that subsequently give rise to gels by formation of an entangled network. The process of hierarchical self-assembly of compound 1 was investigated by the concentration and temperature dependence of UV-visible and 1H NMR spectra, fluorescence spectra, and electron microscopy data. The temperature dependence of the UV-visible spectra indicates a highly cooperative process for the self-assembly of compound 1 in decaline. The electron micrograph of the decaline solution of compound 1 (1.0 mM) revealed supramolecular sheet aggregates forming an entangled network. The selected area electronic diffraction patterns of the supramolecular sheet aggregates were typical for single crystals, indicative of a highly ordered assembly. The results exemplify the generation, by hierarchical self-assembly, of highly organized supramolecular materials presenting novel collective properties at each level of organization.

HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; (I) wherein R1 R2, R4 and X1 are defeined herein, a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATING AGENTS

Compound (I), deuterated derivatives, and pharmaceutically acceptable salts of any of the foregoing are disclosed. Methods of treating cystic fibrosis using these compounds are also disclosed.

PYRIMIDINE DIAMINE DERIVATIVES AS INHIBITORS OF CYTOSOLIC HSP90

The present application describes organic compounds that inhibit the activity of cytosolic heat shock protein Hsp90. Also described are methods useful for prophylaxis, treatment, or amelioration of symptoms of diseases or conditions that are responsive to inhibition of Hsp90 activity, such as neurological diseases, proliferative disorders, and infection.